TickerFacts.

Shattuck Labs, Inc. (STTK): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$3.70M
Year ended 2025-12-31
+6.1%
3-year compound annual growth
+43.9%
5-year compound annual growth
$4.00M2019-12-31: $500.0K2020-12-31: $600.0K2021-12-31: $1.40M2022-12-31: $3.10M2023-12-31: $4.00M2024-12-31: $3.80M2025-12-31: $3.70M$3.70M
2019-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$3.70M-2.6%2026-03-05, From 2025-01-01
2024-12-31$3.80M-5.0%2026-03-05, From 2024-01-01
2023-12-31$4.00M+29.0%2025-03-27, From 2023-01-01
2022-12-31$3.10M+121.4%2024-02-29, From 2022-01-01
2021-12-31$1.40M+133.3%2023-02-23, From 2021-01-01
2020-12-31$600.0K+20.0%2022-03-15, From 2020-01-01
2019-12-31$500.0Kn/a2021-03-16, From 2019-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Shattuck Labs, Inc. (STTK)2025-12-31$3.70M-2.6%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$43.3K+269.5%
Dare Bioscience, Inc. (DARE)2025-12-31$1.63Mn/m
Rafael Holdings, Inc. (RFL)2025-07-31$288.0K+28.0%
China SXT Pharmaceuticals, Inc. (SXTC)2026-03-31$73.7K-10.5%
Rallybio Corp (RLYB)2025-12-31$92.0K-29.8%
Neuphoria Therapeutics Inc. (NEUP)2026-06-30$663.0K0.0%
Longeveron Inc. (LGVN)2025-12-31$800.0K+14.3%
Onconetix, Inc. (ONCO)2025-12-31$15.2K-97.9%

Compare STTK, SXTP, DARE, RFL side by side · Screen every company in Pharmaceutical Preparations ↗